Chief, Dermatology, Division of Subspecialty Medicine | Department of Medicine, Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center•New York, NY

8d•$535,000 - $665,000•Onsite

About The Position

The Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK) is seeking an exceptional academic dermatologist and visionary leader to serve as Chief of the Dermatology Service. This is an extraordinary opportunity to lead one of the nation's premier oncologic dermatology programs and to advance innovation in patient care, research, education, and multidisciplinary collaboration across the cancer continuum. The Dermatology Service is an internationally recognized group of faculty with expertise in the prevention, diagnosis, treatment, and research of skin cancers and skin toxicities related to cancer therapies. The Service faculty provides comprehensive care for patients with melanoma, non-melanoma skin cancers, rare cutaneous malignancies, and dermatologic complications arising from cancer treatment. Faculty members also provide specialized expertise in oncodermatology, Mohs micrographic surgery, dermatologic surgery, advanced imaging, and dermatology informatics. The Service is distinguished by its multidisciplinary approach to care, partnering closely with colleagues across Medical Oncology, Surgical Oncology, Radiation Oncology, Pathology, Radiology, Plastic Surgery, Immunology, and other clinical specialties to deliver personalized care for patients throughout the cancer continuum. The Service Chief will report to the Head of the Division of Subspecialty Medicine and will provide strategic, clinical, academic, and operational leadership for the Dermatology Service. The Chief will be responsible for advancing the Service's clinical excellence, research portfolio, educational mission, faculty development, philanthropy, and impact on the management of cutaneous malignancies and dermatologic manifestations of cancer and its treatment worldwide. The Service Chief will oversee clinical operations, faculty recruitment and retention, mentorship, quality improvement, strategic growth, and collaborations across Memorial Sloan Kettering while fostering innovation in patient care and translational research. The clinical, research, and educational mission of the Dermatology Service is organized around six strategic pillars: Cutaneous Oncology, Oncodermatology, Procedural Dermatology, Innovation in Dermatologic Imaging and Technology, Research and Innovation, and Education, and Faculty Development.

Requirements

Board-certified in Dermatology.
A compelling vision for the future of academic dermatology within a world-leading comprehensive cancer center.
National or international recognition as an academic leader with a distinguished record of clinical excellence, education, research, and program development.
Demonstrated success leading multidisciplinary clinical and academic programs.
A strong record of scholarly achievement, including peer-reviewed publications, grant funding, clinical research, translational investigation, or innovation in dermatology.
A demonstrated commitment to mentorship, faculty development, diversity, equity, and inclusion.
Eligibility for appointment at the Associate Professor or Professor level, commensurate with experience.

Nice To Haves

Expertise and focus on either medical dermatology or surgical dermatology (Mohs).

Responsibilities

Provide strategic, clinical, academic, and operational leadership for the Dermatology Service.
Advance the Service's clinical excellence, research portfolio, educational mission, faculty development, philanthropy, and impact on the management of cutaneous malignancies and dermatologic manifestations of cancer and its treatment worldwide.
Oversee clinical operations, faculty recruitment and retention, mentorship, quality improvement, strategic growth, and collaborations across Memorial Sloan Kettering.
Foster innovation in patient care and translational research.
Lead the continued advancement of comprehensive multidisciplinary care for patients with melanoma, basal cell carcinoma, squamous cell carcinoma, Merkel cell carcinoma, cutaneous lymphomas, and other rare skin malignancies.
Promote innovations in prevention, diagnosis, treatment, and survivorship for patients with skin cancer.
Advance programs dedicated to preventing, diagnosing, and managing dermatologic toxicities associated with systemic therapies, radiation therapy, stem cell transplantation, and immunotherapy.
Continue developing evidence-based approaches that improve quality of life while enabling patients to remain on life-saving cancer treatments.
Advance excellence in Mohs micrographic surgery, dermatologic surgery, laser therapies, photodynamic therapy, photobiomodulation, and reconstructive approaches that maximize oncologic control while preserving function and appearance.
Expand MSK's leadership in non-invasive imaging technologies, including reflectance confocal microscopy, digital dermoscopy, total body photography, artificial intelligence, and dermatology informatics.
Foster collaborations that accelerate precision diagnostics and improve early detection of skin cancer.
Build upon MSK's internationally recognized research portfolio in skin cancer biology, imaging technologies, artificial intelligence, clinical trials, prevention, survivorship, and supportive care.
Develop collaborative research programs spanning clinical trials, imaging technologies, artificial intelligence, implementation science, and translational investigations that improve the prevention, diagnosis, and treatment of skin cancers and dermatologic complications of cancer therapy.
Foster collaborations across MSK's research enterprise to expand investigator-initiated clinical trials, translational science, implementation research, and technology development.
Strengthen the Service's translational, clinical, and population science research portfolio while expanding educational programs, including multiple fellowships, residency training, visiting scholars, and multidisciplinary educational initiatives.
Cultivate the next generation of leaders in dermato-oncology and oncodermatology.